| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mannose-Binding Lectin | 46 | 2016 | 146 | 5.760 |
Why?
|
| Complement Activation | 18 | 2016 | 447 | 1.650 |
Why?
|
| Mannose-Binding Protein-Associated Serine Proteases | 9 | 2012 | 20 | 1.240 |
Why?
|
| Disseminated Intravascular Coagulation | 3 | 2014 | 187 | 1.130 |
Why?
|
| Lectins | 7 | 2016 | 490 | 1.090 |
Why?
|
| Mannose-Binding Lectins | 6 | 2013 | 101 | 1.000 |
Why?
|
| Complement Pathway, Mannose-Binding Lectin | 14 | 2014 | 28 | 1.000 |
Why?
|
| Complement Pathway, Alternative | 12 | 2014 | 113 | 0.990 |
Why?
|
| Teichoic Acids | 6 | 2016 | 70 | 0.860 |
Why?
|
| Thrombin | 5 | 2021 | 600 | 0.850 |
Why?
|
| Staphylococcal Infections | 9 | 2016 | 1398 | 0.820 |
Why?
|
| Complement C3 | 9 | 2012 | 434 | 0.790 |
Why?
|
| Complement Factor B | 3 | 2021 | 57 | 0.790 |
Why?
|
| Orthomyxoviridae Infections | 4 | 2013 | 255 | 0.760 |
Why?
|
| Complement System Proteins | 9 | 2016 | 738 | 0.730 |
Why?
|
| Influenza A virus | 5 | 2014 | 460 | 0.720 |
Why?
|
| Trypsin | 1 | 2021 | 491 | 0.700 |
Why?
|
| Staphylococcus aureus | 12 | 2016 | 1430 | 0.690 |
Why?
|
| Collectins | 4 | 2016 | 18 | 0.660 |
Why?
|
| Cell Wall | 5 | 2016 | 421 | 0.640 |
Why?
|
| Immunity, Innate | 12 | 2016 | 3080 | 0.550 |
Why?
|
| Arthritis, Experimental | 7 | 2013 | 293 | 0.530 |
Why?
|
| Mice, Knockout | 40 | 2021 | 14488 | 0.460 |
Why?
|
| Ventilator-Induced Lung Injury | 2 | 2013 | 135 | 0.440 |
Why?
|
| Antiviral Agents | 6 | 2013 | 3073 | 0.440 |
Why?
|
| Immunoglobulin G | 10 | 2016 | 4568 | 0.420 |
Why?
|
| Mice | 69 | 2024 | 82029 | 0.410 |
Why?
|
| Mice, Inbred C57BL | 37 | 2024 | 22379 | 0.400 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2013 | 355 | 0.390 |
Why?
|
| Disease Susceptibility | 6 | 2011 | 1793 | 0.370 |
Why?
|
| Blood Coagulation | 3 | 2011 | 1162 | 0.370 |
Why?
|
| Phagocytosis | 9 | 2016 | 1530 | 0.370 |
Why?
|
| Receptors, Pattern Recognition | 2 | 2012 | 81 | 0.360 |
Why?
|
| Radiopharmaceuticals | 6 | 2024 | 2735 | 0.360 |
Why?
|
| Inflammation | 15 | 2014 | 10873 | 0.350 |
Why?
|
| Reperfusion Injury | 8 | 2012 | 1039 | 0.340 |
Why?
|
| Animals | 82 | 2024 | 169246 | 0.340 |
Why?
|
| Positron-Emission Tomography | 8 | 2024 | 6669 | 0.320 |
Why?
|
| Influenza, Human | 4 | 2016 | 1541 | 0.290 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 4 | 2016 | 452 | 0.280 |
Why?
|
| Immunologic Factors | 2 | 2013 | 1596 | 0.280 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2010 | 3740 | 0.280 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2013 | 704 | 0.270 |
Why?
|
| Technetium Tc 99m Aggregated Albumin | 1 | 2006 | 67 | 0.270 |
Why?
|
| Technetium Tc 99m Pentetate | 1 | 2006 | 67 | 0.260 |
Why?
|
| Complement C1q | 8 | 2012 | 93 | 0.260 |
Why?
|
| Complement Pathway, Classical | 6 | 2014 | 91 | 0.260 |
Why?
|
| Horse Diseases | 1 | 2006 | 55 | 0.260 |
Why?
|
| Dermis | 1 | 2007 | 203 | 0.250 |
Why?
|
| Antibody Formation | 2 | 2010 | 1393 | 0.240 |
Why?
|
| Burns | 2 | 2007 | 1899 | 0.240 |
Why?
|
| Fluorine Radioisotopes | 2 | 2024 | 425 | 0.240 |
Why?
|
| Ebolavirus | 3 | 2013 | 250 | 0.240 |
Why?
|
| Opsonin Proteins | 5 | 2016 | 144 | 0.230 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2018 | 297 | 0.230 |
Why?
|
| Epidermis | 1 | 2007 | 539 | 0.230 |
Why?
|
| Interleukin-6 | 5 | 2019 | 3228 | 0.220 |
Why?
|
| Mannose | 3 | 2010 | 122 | 0.220 |
Why?
|
| Kv1.2 Potassium Channel | 1 | 2022 | 16 | 0.210 |
Why?
|
| Kv1.1 Potassium Channel | 1 | 2022 | 31 | 0.210 |
Why?
|
| Radioactive Tracers | 1 | 2022 | 68 | 0.200 |
Why?
|
| 4-Aminopyridine | 1 | 2022 | 81 | 0.200 |
Why?
|
| Amyloid beta-Peptides | 2 | 2014 | 3914 | 0.200 |
Why?
|
| Thiourea | 1 | 2022 | 68 | 0.200 |
Why?
|
| Pseudomonas Infections | 1 | 2006 | 623 | 0.190 |
Why?
|
| Disease Models, Animal | 14 | 2018 | 18349 | 0.190 |
Why?
|
| Immunoglobulin M | 5 | 2010 | 1528 | 0.180 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2006 | 1140 | 0.180 |
Why?
|
| Isoflurane | 1 | 2024 | 384 | 0.180 |
Why?
|
| Calcium Channels, L-Type | 1 | 2022 | 244 | 0.180 |
Why?
|
| Glycoproteins | 4 | 2016 | 2202 | 0.180 |
Why?
|
| Immunization | 4 | 2016 | 1219 | 0.180 |
Why?
|
| Communicable Diseases | 2 | 2008 | 874 | 0.180 |
Why?
|
| Antibodies, Bacterial | 4 | 2016 | 1479 | 0.170 |
Why?
|
| Demyelinating Diseases | 1 | 2022 | 358 | 0.170 |
Why?
|
| Peritonitis | 1 | 2002 | 368 | 0.170 |
Why?
|
| Bronchoalveolar Lavage Fluid | 3 | 2011 | 760 | 0.170 |
Why?
|
| Complement C4 | 5 | 2012 | 216 | 0.160 |
Why?
|
| Myocardium | 4 | 2012 | 4788 | 0.160 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2008 | 18065 | 0.160 |
Why?
|
| Collagen Type II | 2 | 2009 | 151 | 0.150 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2020 | 2055 | 0.150 |
Why?
|
| Phagosomes | 2 | 2010 | 198 | 0.150 |
Why?
|
| Phylogeny | 2 | 2021 | 2843 | 0.140 |
Why?
|
| Liver Diseases | 1 | 2006 | 1305 | 0.140 |
Why?
|
| Molecular Imaging | 2 | 2022 | 826 | 0.140 |
Why?
|
| Antigen-Antibody Complex | 5 | 2012 | 513 | 0.140 |
Why?
|
| Matrix Metalloproteinases | 2 | 2011 | 393 | 0.140 |
Why?
|
| Toll-Like Receptors | 3 | 2009 | 582 | 0.140 |
Why?
|
| Phosphatidylcholines | 1 | 2018 | 406 | 0.140 |
Why?
|
| Ligands | 4 | 2024 | 3284 | 0.140 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2021 | 2748 | 0.140 |
Why?
|
| Lymphangioleiomyomatosis | 1 | 2018 | 207 | 0.130 |
Why?
|
| Macrophages, Alveolar | 2 | 2014 | 415 | 0.130 |
Why?
|
| Neuralgia | 1 | 2022 | 621 | 0.130 |
Why?
|
| Complement C6 | 2 | 2012 | 14 | 0.130 |
Why?
|
| Brain | 6 | 2024 | 27360 | 0.130 |
Why?
|
| Polysaccharides | 3 | 2012 | 1024 | 0.120 |
Why?
|
| Adipocytes | 2 | 2013 | 1197 | 0.120 |
Why?
|
| Models, Biological | 3 | 2012 | 9495 | 0.120 |
Why?
|
| Liver | 3 | 2010 | 7577 | 0.120 |
Why?
|
| Mice, Mutant Strains | 3 | 2007 | 1754 | 0.120 |
Why?
|
| Respiratory Mechanics | 1 | 2019 | 721 | 0.120 |
Why?
|
| Amino Acid Sequence | 3 | 2021 | 13421 | 0.120 |
Why?
|
| Cromolyn Sodium | 1 | 2014 | 78 | 0.120 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2016 | 352 | 0.120 |
Why?
|
| Extracorporeal Circulation | 1 | 2014 | 181 | 0.110 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2009 | 483 | 0.110 |
Why?
|
| Filoviridae Infections | 1 | 2013 | 6 | 0.110 |
Why?
|
| Injections, Intradermal | 1 | 2013 | 117 | 0.110 |
Why?
|
| Neutrophils | 4 | 2016 | 3786 | 0.110 |
Why?
|
| Binding Sites | 2 | 2021 | 6020 | 0.110 |
Why?
|
| Receptor, Anaphylatoxin C5a | 2 | 2011 | 87 | 0.110 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2016 | 582 | 0.110 |
Why?
|
| Receptors, Mitogen | 1 | 2013 | 61 | 0.110 |
Why?
|
| Respiratory Mucosa | 1 | 2016 | 439 | 0.110 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2006 | 3390 | 0.110 |
Why?
|
| Artificial Organs | 1 | 2014 | 149 | 0.110 |
Why?
|
| Receptors, Complement | 2 | 2011 | 254 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2014 | 3814 | 0.100 |
Why?
|
| Solubility | 3 | 2010 | 1083 | 0.100 |
Why?
|
| Cell Division | 1 | 2020 | 4473 | 0.100 |
Why?
|
| Onium Compounds | 1 | 2012 | 27 | 0.100 |
Why?
|
| Neutralization Tests | 2 | 2012 | 739 | 0.100 |
Why?
|
| Influenza A Virus, H9N2 Subtype | 1 | 2011 | 8 | 0.100 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2012 | 85 | 0.100 |
Why?
|
| Carotid Artery Thrombosis | 1 | 2011 | 49 | 0.100 |
Why?
|
| Autoradiography | 1 | 2013 | 727 | 0.100 |
Why?
|
| Cell Cycle | 1 | 2020 | 2932 | 0.100 |
Why?
|
| Cytochrome P-450 CYP2E1 | 1 | 2011 | 41 | 0.100 |
Why?
|
| Recombinant Proteins | 6 | 2014 | 6514 | 0.100 |
Why?
|
| Cryptococcus | 1 | 2011 | 28 | 0.090 |
Why?
|
| Spleen | 3 | 2014 | 2295 | 0.090 |
Why?
|
| Endotoxemia | 1 | 2013 | 198 | 0.090 |
Why?
|
| B-Lymphocyte Subsets | 2 | 2010 | 241 | 0.090 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2011 | 88 | 0.090 |
Why?
|
| Antigens, Fungal | 1 | 2011 | 69 | 0.090 |
Why?
|
| Blood Coagulation Disorders | 1 | 2014 | 350 | 0.090 |
Why?
|
| Hemagglutination, Viral | 1 | 2010 | 12 | 0.090 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2013 | 292 | 0.090 |
Why?
|
| Peptide Fragments | 4 | 2014 | 5151 | 0.090 |
Why?
|
| Organophosphorus Compounds | 1 | 2012 | 211 | 0.090 |
Why?
|
| Leukocytes | 2 | 2013 | 2035 | 0.090 |
Why?
|
| Chagas Disease | 1 | 2012 | 166 | 0.090 |
Why?
|
| Epitopes | 2 | 2016 | 2528 | 0.090 |
Why?
|
| Antibodies, Fungal | 1 | 2010 | 33 | 0.090 |
Why?
|
| Trypanosoma cruzi | 1 | 2012 | 204 | 0.090 |
Why?
|
| Mitochondria, Heart | 1 | 2012 | 236 | 0.090 |
Why?
|
| Inflammation Mediators | 2 | 2012 | 1892 | 0.090 |
Why?
|
| Central Nervous System Depressants | 1 | 2011 | 163 | 0.090 |
Why?
|
| Host-Parasite Interactions | 1 | 2012 | 303 | 0.090 |
Why?
|
| Aminopyridines | 2 | 2024 | 580 | 0.090 |
Why?
|
| Neuraminidase | 1 | 2010 | 195 | 0.090 |
Why?
|
| Tuberous Sclerosis | 1 | 2018 | 1042 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2016 | 4352 | 0.090 |
Why?
|
| Complement C3a | 2 | 2011 | 66 | 0.090 |
Why?
|
| Protein Binding | 6 | 2016 | 9343 | 0.080 |
Why?
|
| Nod Signaling Adaptor Proteins | 1 | 2009 | 1 | 0.080 |
Why?
|
| Viral Load | 4 | 2016 | 3396 | 0.080 |
Why?
|
| Complement Inactivator Proteins | 1 | 2009 | 74 | 0.080 |
Why?
|
| Phagocytes | 1 | 2011 | 294 | 0.080 |
Why?
|
| Complement Factor D | 4 | 2011 | 67 | 0.080 |
Why?
|
| Receptors, Complement 3d | 1 | 2009 | 117 | 0.080 |
Why?
|
| Complement Factor H | 1 | 2009 | 110 | 0.080 |
Why?
|
| Virus Internalization | 1 | 2013 | 504 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2012 | 10760 | 0.080 |
Why?
|
| Hemangioma | 1 | 1994 | 727 | 0.080 |
Why?
|
| Coxiella burnetii | 1 | 2009 | 37 | 0.080 |
Why?
|
| Respiratory Tract Diseases | 1 | 2014 | 744 | 0.080 |
Why?
|
| Humans | 45 | 2021 | 768166 | 0.080 |
Why?
|
| Immunohistochemistry | 9 | 2018 | 11095 | 0.080 |
Why?
|
| Hepatitis B Antibodies | 1 | 2009 | 156 | 0.080 |
Why?
|
| Cytokines | 6 | 2019 | 7453 | 0.080 |
Why?
|
| Virus Replication | 2 | 2016 | 2458 | 0.080 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2008 | 348 | 0.080 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 2540 | 0.080 |
Why?
|
| Toll-Like Receptor 6 | 1 | 2008 | 29 | 0.080 |
Why?
|
| Macrophages | 3 | 2012 | 5799 | 0.070 |
Why?
|
| Epidermolysis Bullosa Acquisita | 1 | 2007 | 15 | 0.070 |
Why?
|
| Pneumococcal Infections | 1 | 2012 | 529 | 0.070 |
Why?
|
| Drug Approval | 1 | 2014 | 821 | 0.070 |
Why?
|
| Adoptive Transfer | 1 | 2010 | 825 | 0.070 |
Why?
|
| Respiration, Artificial | 1 | 2019 | 2726 | 0.070 |
Why?
|
| Choroidal Neovascularization | 1 | 2011 | 364 | 0.070 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2007 | 61 | 0.070 |
Why?
|
| Rats | 5 | 2022 | 23760 | 0.070 |
Why?
|
| Complement C4b | 1 | 2007 | 124 | 0.070 |
Why?
|
| Pneumonia | 1 | 2019 | 2163 | 0.070 |
Why?
|
| Dimerization | 1 | 2008 | 887 | 0.070 |
Why?
|
| Blister | 1 | 2007 | 88 | 0.070 |
Why?
|
| Genetic Variation | 2 | 2021 | 6611 | 0.070 |
Why?
|
| Leukocyte Count | 1 | 2010 | 1609 | 0.070 |
Why?
|
| Streptococcus pneumoniae | 1 | 2012 | 764 | 0.070 |
Why?
|
| Sepsis | 2 | 2014 | 2608 | 0.070 |
Why?
|
| Lasers | 1 | 2011 | 952 | 0.070 |
Why?
|
| Seasons | 1 | 2012 | 1524 | 0.070 |
Why?
|
| Models, Immunological | 1 | 2008 | 518 | 0.070 |
Why?
|
| Octamer Transcription Factor-3 | 1 | 2007 | 221 | 0.070 |
Why?
|
| Myocardial Perfusion Imaging | 1 | 2012 | 672 | 0.060 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2010 | 582 | 0.060 |
Why?
|
| Apoptosis | 3 | 2014 | 9523 | 0.060 |
Why?
|
| Metabolic Clearance Rate | 1 | 2006 | 363 | 0.060 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2011 | 424 | 0.060 |
Why?
|
| Cell Line | 5 | 2013 | 15597 | 0.060 |
Why?
|
| Brain Injuries | 2 | 2008 | 2057 | 0.060 |
Why?
|
| Receptors, Fc | 1 | 2009 | 537 | 0.060 |
Why?
|
| Horses | 1 | 2006 | 295 | 0.060 |
Why?
|
| Models, Animal | 2 | 2008 | 2120 | 0.060 |
Why?
|
| Ethanol | 1 | 2011 | 1331 | 0.060 |
Why?
|
| Dermatitis | 1 | 2007 | 203 | 0.060 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2005 | 221 | 0.060 |
Why?
|
| Mitochondria | 1 | 2018 | 3681 | 0.060 |
Why?
|
| Permeability | 2 | 2022 | 725 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2020 | 10474 | 0.060 |
Why?
|
| Disulfiram | 1 | 2024 | 63 | 0.060 |
Why?
|
| Blotting, Western | 4 | 2013 | 5027 | 0.060 |
Why?
|
| Isoantibodies | 1 | 2007 | 681 | 0.050 |
Why?
|
| Cation Transport Proteins | 1 | 2006 | 326 | 0.050 |
Why?
|
| Herpesvirus 2, Human | 1 | 2004 | 191 | 0.050 |
Why?
|
| Risk Factors | 4 | 2014 | 74944 | 0.050 |
Why?
|
| Male | 23 | 2024 | 364719 | 0.050 |
Why?
|
| Airway Resistance | 1 | 2004 | 407 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2013 | 4176 | 0.050 |
Why?
|
| Kinetics | 2 | 2010 | 6329 | 0.050 |
Why?
|
| Up-Regulation | 2 | 2008 | 4146 | 0.050 |
Why?
|
| Bacteremia | 2 | 2005 | 986 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2013 | 4580 | 0.050 |
Why?
|
| Potassium Channels | 1 | 2024 | 538 | 0.050 |
Why?
|
| Colitis | 1 | 2010 | 1242 | 0.050 |
Why?
|
| Substrate Specificity | 1 | 2005 | 1751 | 0.050 |
Why?
|
| Sequence Alignment | 1 | 2006 | 2179 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 2 | 2009 | 9263 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2013 | 3703 | 0.050 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2006 | 621 | 0.050 |
Why?
|
| Age Factors | 2 | 2016 | 18412 | 0.050 |
Why?
|
| Cells, Cultured | 6 | 2016 | 19015 | 0.050 |
Why?
|
| Calcium | 2 | 2012 | 5792 | 0.050 |
Why?
|
| Herpes Simplex | 1 | 2004 | 470 | 0.050 |
Why?
|
| Haplotypes | 1 | 2007 | 2722 | 0.050 |
Why?
|
| Molecular Sequence Data | 3 | 2014 | 17622 | 0.050 |
Why?
|
| Organ Specificity | 1 | 2006 | 1968 | 0.050 |
Why?
|
| Pulmonary Surfactant-Associated Protein D | 2 | 2016 | 49 | 0.050 |
Why?
|
| Pneumocystis | 1 | 2000 | 55 | 0.040 |
Why?
|
| Mycoses | 1 | 2004 | 386 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2024 | 1883 | 0.040 |
Why?
|
| Pluripotent Stem Cells | 1 | 2007 | 809 | 0.040 |
Why?
|
| Primates | 1 | 2022 | 520 | 0.040 |
Why?
|
| Kidney | 3 | 2010 | 7064 | 0.040 |
Why?
|
| Movement | 1 | 2007 | 1490 | 0.040 |
Why?
|
| Embryonic Stem Cells | 1 | 2007 | 1250 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2013 | 3589 | 0.040 |
Why?
|
| Retina | 1 | 2011 | 2662 | 0.040 |
Why?
|
| Adaptive Immunity | 2 | 2016 | 733 | 0.040 |
Why?
|
| Lung | 5 | 2011 | 10099 | 0.040 |
Why?
|
| Pulmonary Surfactants | 1 | 2000 | 169 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2011 | 3329 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2010 | 3044 | 0.040 |
Why?
|
| Brain Ischemia | 1 | 2012 | 3007 | 0.040 |
Why?
|
| Gastrointestinal Tract | 1 | 2005 | 840 | 0.040 |
Why?
|
| Anesthetics, Inhalation | 1 | 2024 | 573 | 0.040 |
Why?
|
| Anaphylaxis | 1 | 2006 | 758 | 0.040 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 2000 | 242 | 0.040 |
Why?
|
| Fluoroacetates | 1 | 2018 | 14 | 0.040 |
Why?
|
| Receptors, IgG | 1 | 2002 | 564 | 0.040 |
Why?
|
| Homeostasis | 2 | 2007 | 3348 | 0.040 |
Why?
|
| Coronary Artery Bypass | 1 | 2007 | 2191 | 0.040 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2006 | 1276 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2009 | 2747 | 0.040 |
Why?
|
| Female | 15 | 2018 | 397192 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2007 | 2857 | 0.040 |
Why?
|
| Surface Plasmon Resonance | 2 | 2010 | 272 | 0.040 |
Why?
|
| Bacterial Infections | 1 | 2005 | 1397 | 0.040 |
Why?
|
| RNA Interference | 1 | 2006 | 2832 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2000 | 594 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2005 | 1361 | 0.030 |
Why?
|
| Mice, Transgenic | 3 | 2018 | 9561 | 0.030 |
Why?
|
| Cathelicidins | 1 | 2016 | 81 | 0.030 |
Why?
|
| Choline | 1 | 2018 | 522 | 0.030 |
Why?
|
| Serum Amyloid P-Component | 1 | 2016 | 46 | 0.030 |
Why?
|
| Cystic Fibrosis | 1 | 2005 | 1294 | 0.030 |
Why?
|
| Host-Pathogen Interactions | 2 | 2016 | 1469 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2022 | 1034 | 0.030 |
Why?
|
| Complement C2 | 2 | 2005 | 45 | 0.030 |
Why?
|
| Receptors, Cell Surface | 2 | 2005 | 2819 | 0.030 |
Why?
|
| B-Lymphocytes | 1 | 2008 | 4793 | 0.030 |
Why?
|
| Phenotype | 3 | 2010 | 16726 | 0.030 |
Why?
|
| Base Sequence | 1 | 2006 | 12421 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2011 | 10101 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2002 | 2675 | 0.030 |
Why?
|
| Flavonols | 1 | 2014 | 84 | 0.030 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 1994 | 97 | 0.030 |
Why?
|
| Respiratory Function Tests | 1 | 2019 | 1695 | 0.030 |
Why?
|
| Aged | 6 | 2018 | 171504 | 0.030 |
Why?
|
| HeLa Cells | 1 | 2020 | 3074 | 0.030 |
Why?
|
| Collagenases | 1 | 1994 | 221 | 0.030 |
Why?
|
| Heart Transplantation | 1 | 2007 | 3301 | 0.030 |
Why?
|
| U937 Cells | 1 | 2014 | 260 | 0.030 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 1994 | 284 | 0.030 |
Why?
|
| Mast Cells | 2 | 2006 | 1406 | 0.030 |
Why?
|
| Autoimmune Diseases | 1 | 2005 | 2257 | 0.030 |
Why?
|
| Pinocytosis | 1 | 2013 | 63 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2009 | 11669 | 0.030 |
Why?
|
| Biomedical Engineering | 1 | 2014 | 286 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2014 | 8759 | 0.030 |
Why?
|
| Brain Edema | 2 | 2008 | 601 | 0.030 |
Why?
|
| Complement Fixation Tests | 1 | 2012 | 68 | 0.030 |
Why?
|
| Biomimetic Materials | 1 | 2014 | 173 | 0.030 |
Why?
|
| Protein Engineering | 1 | 2016 | 553 | 0.030 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2012 | 59 | 0.030 |
Why?
|
| Heart | 1 | 2006 | 4446 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2014 | 687 | 0.030 |
Why?
|
| Acute Kidney Injury | 1 | 2005 | 1942 | 0.030 |
Why?
|
| Complement Membrane Attack Complex | 1 | 2012 | 105 | 0.030 |
Why?
|
| Dogs | 2 | 2012 | 3845 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 1994 | 748 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 2 | 2013 | 3781 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 2011 | 1972 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2006 | 6283 | 0.030 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2013 | 167 | 0.020 |
Why?
|
| Pandemics | 1 | 2012 | 8748 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2012 | 6568 | 0.020 |
Why?
|
| Alanine Transaminase | 2 | 2005 | 606 | 0.020 |
Why?
|
| Endotoxins | 1 | 2014 | 519 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1994 | 590 | 0.020 |
Why?
|
| Vero Cells | 1 | 2013 | 486 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2018 | 1880 | 0.020 |
Why?
|
| Endothelial Growth Factors | 1 | 1994 | 671 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 41754 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2016 | 965 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2011 | 3514 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2006 | 4978 | 0.020 |
Why?
|
| Magnetics | 1 | 2014 | 597 | 0.020 |
Why?
|
| Flavonoids | 1 | 2014 | 447 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2022 | 8128 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2006 | 3447 | 0.020 |
Why?
|
| Viral Matrix Proteins | 1 | 2012 | 193 | 0.020 |
Why?
|
| Lymphokines | 1 | 1994 | 924 | 0.020 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 1994 | 633 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 14729 | 0.020 |
Why?
|
| Rabbits | 2 | 2007 | 4772 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2012 | 430 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2014 | 1888 | 0.020 |
Why?
|
| Escherichia coli | 2 | 2014 | 4214 | 0.020 |
Why?
|
| Stroke | 1 | 2012 | 9755 | 0.020 |
Why?
|
| Middle Aged | 5 | 2014 | 223492 | 0.020 |
Why?
|
| Synovial Membrane | 1 | 2013 | 536 | 0.020 |
Why?
|
| Ferric Compounds | 1 | 2011 | 376 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2007 | 9615 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 1904 | 0.020 |
Why?
|
| Immune System | 2 | 2008 | 799 | 0.020 |
Why?
|
| Synovial Fluid | 1 | 2011 | 393 | 0.020 |
Why?
|
| Microscopy, Atomic Force | 1 | 2010 | 250 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2013 | 65371 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2010 | 611 | 0.020 |
Why?
|
| Viral Envelope Proteins | 1 | 2013 | 640 | 0.020 |
Why?
|
| Stem Cells | 1 | 2002 | 3537 | 0.020 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2010 | 273 | 0.020 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2011 | 203 | 0.020 |
Why?
|
| Calreticulin | 1 | 2010 | 115 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 6082 | 0.020 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2011 | 254 | 0.020 |
Why?
|
| Acute Lung Injury | 1 | 2013 | 377 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 2011 | 5902 | 0.020 |
Why?
|
| Membrane Glycoproteins | 2 | 2013 | 3711 | 0.020 |
Why?
|
| Chlorides | 1 | 2011 | 666 | 0.020 |
Why?
|
| Q Fever | 1 | 2009 | 38 | 0.020 |
Why?
|
| Electroretinography | 1 | 2011 | 524 | 0.020 |
Why?
|
| Oximetry | 1 | 2012 | 462 | 0.020 |
Why?
|
| Cricetulus | 1 | 2010 | 812 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2012 | 1375 | 0.020 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2009 | 294 | 0.020 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2014 | 820 | 0.020 |
Why?
|
| Antibody-Dependent Cell Cytotoxicity | 1 | 2009 | 306 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 20227 | 0.020 |
Why?
|
| Candidiasis | 1 | 2010 | 367 | 0.020 |
Why?
|
| Swine | 1 | 2018 | 5995 | 0.020 |
Why?
|
| Microscopy | 1 | 2013 | 909 | 0.020 |
Why?
|
| Zymosan | 1 | 2007 | 134 | 0.020 |
Why?
|
| CHO Cells | 1 | 2010 | 1379 | 0.020 |
Why?
|
| Cations, Divalent | 1 | 2007 | 167 | 0.020 |
Why?
|
| Collagen Type VII | 1 | 2007 | 22 | 0.020 |
Why?
|
| Chemokines | 1 | 2011 | 963 | 0.020 |
Why?
|
| Candida albicans | 1 | 2010 | 375 | 0.020 |
Why?
|
| Carbohydrates | 1 | 2009 | 389 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2000 | 4937 | 0.020 |
Why?
|
| Immune Sera | 1 | 2007 | 605 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2010 | 557 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2009 | 393 | 0.020 |
Why?
|
| Immunity, Mucosal | 1 | 2010 | 498 | 0.020 |
Why?
|
| Immunization, Passive | 1 | 2009 | 619 | 0.020 |
Why?
|
| Myosin Type II | 1 | 2006 | 71 | 0.020 |
Why?
|
| Adult | 7 | 2013 | 223646 | 0.020 |
Why?
|
| Cricetinae | 1 | 2010 | 2423 | 0.020 |
Why?
|
| Signal Transduction | 3 | 2009 | 23645 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2007 | 11519 | 0.020 |
Why?
|
| Infant | 3 | 2013 | 36535 | 0.020 |
Why?
|
| Equipment Design | 1 | 2014 | 3522 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2014 | 1673 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 2 | 2005 | 3772 | 0.020 |
Why?
|
| Mutation | 2 | 2013 | 30238 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2008 | 399 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2005 | 16045 | 0.020 |
Why?
|
| Mesentery | 1 | 2006 | 202 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2014 | 2149 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2007 | 6231 | 0.020 |
Why?
|
| Coronary Circulation | 1 | 2012 | 1617 | 0.020 |
Why?
|
| Microglia | 1 | 2014 | 1376 | 0.020 |
Why?
|
| Cell Separation | 1 | 2011 | 1728 | 0.020 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2007 | 286 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2010 | 2486 | 0.020 |
Why?
|
| Fibrosis | 1 | 2012 | 2080 | 0.020 |
Why?
|
| Mice, Inbred DBA | 1 | 2006 | 624 | 0.020 |
Why?
|
| Maze Learning | 1 | 2007 | 482 | 0.020 |
Why?
|
| Receptors, Scavenger | 1 | 2005 | 123 | 0.020 |
Why?
|
| Troponin I | 1 | 2009 | 662 | 0.020 |
Why?
|
| Drug Design | 1 | 2010 | 1046 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2007 | 15832 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2010 | 59629 | 0.010 |
Why?
|
| Myosin Heavy Chains | 1 | 2006 | 404 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 1765 | 0.010 |
Why?
|
| Asthma | 1 | 2004 | 6291 | 0.010 |
Why?
|
| Hypothermia | 1 | 2006 | 189 | 0.010 |
Why?
|
| Cell Line, Tumor | 2 | 2012 | 17140 | 0.010 |
Why?
|
| Macrophages, Peritoneal | 1 | 2005 | 244 | 0.010 |
Why?
|
| Ovalbumin | 1 | 2006 | 677 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2013 | 6229 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2006 | 874 | 0.010 |
Why?
|
| Encephalitis | 1 | 2008 | 441 | 0.010 |
Why?
|
| Cattle | 1 | 2009 | 3819 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 2011 | 12800 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2013 | 4283 | 0.010 |
Why?
|
| Antigens, Bacterial | 1 | 2009 | 1150 | 0.010 |
Why?
|
| Infant, Newborn | 2 | 2013 | 26422 | 0.010 |
Why?
|
| Antibodies, Antinuclear | 1 | 2005 | 342 | 0.010 |
Why?
|
| Herpes Genitalis | 1 | 2004 | 149 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2010 | 2633 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2009 | 2089 | 0.010 |
Why?
|
| Dextrans | 1 | 2005 | 574 | 0.010 |
Why?
|
| Capillary Permeability | 1 | 2006 | 772 | 0.010 |
Why?
|
| Kidney Tubules | 1 | 2005 | 454 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2006 | 809 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 8054 | 0.010 |
Why?
|
| Interleukin-12 | 1 | 2005 | 577 | 0.010 |
Why?
|
| Aspergillus fumigatus | 1 | 2004 | 158 | 0.010 |
Why?
|
| Cell Death | 1 | 2008 | 1679 | 0.010 |
Why?
|
| Autoantigens | 1 | 2006 | 890 | 0.010 |
Why?
|
| Germinal Center | 1 | 2005 | 380 | 0.010 |
Why?
|
| Embryonic Development | 1 | 2007 | 724 | 0.010 |
Why?
|
| Peroxidase | 1 | 2005 | 610 | 0.010 |
Why?
|
| Mice, Inbred NOD | 1 | 2006 | 1837 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 2005 | 960 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2018 | 9015 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2012 | 4194 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2007 | 1750 | 0.010 |
Why?
|
| Hemagglutination Inhibition Tests | 1 | 2000 | 87 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2005 | 1505 | 0.010 |
Why?
|
| Necrosis | 1 | 2005 | 1616 | 0.010 |
Why?
|
| Monosaccharides | 1 | 2000 | 64 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2007 | 1367 | 0.010 |
Why?
|
| Cardiomyopathies | 1 | 2012 | 2056 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2013 | 3840 | 0.010 |
Why?
|
| Weight Loss | 1 | 2011 | 2721 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2010 | 2682 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 1994 | 5804 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2008 | 1896 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 1994 | 11244 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2006 | 2202 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 2004 | 1478 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 2005 | 1418 | 0.010 |
Why?
|
| Serine Endopeptidases | 1 | 2004 | 1027 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 20760 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2007 | 4833 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2007 | 1892 | 0.010 |
Why?
|
| Autoantibodies | 1 | 2007 | 2121 | 0.010 |
Why?
|
| Colitis, Ulcerative | 1 | 2010 | 1926 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2000 | 694 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2007 | 2429 | 0.010 |
Why?
|
| Crohn Disease | 1 | 2010 | 2295 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2005 | 2219 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2008 | 2981 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2004 | 1802 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 4249 | 0.010 |
Why?
|
| Reference Values | 1 | 2004 | 4938 | 0.010 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2000 | 664 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 2009 | 3941 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2009 | 6004 | 0.010 |
Why?
|
| Intestines | 1 | 2005 | 1909 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2005 | 1712 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2007 | 3610 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2009 | 5622 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2000 | 2627 | 0.010 |
Why?
|
| Hypersensitivity | 1 | 2004 | 1172 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2005 | 5505 | 0.010 |
Why?
|
| Adolescent | 2 | 2010 | 89169 | 0.010 |
Why?
|
| Genotype | 1 | 2007 | 13045 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 11928 | 0.010 |
Why?
|
| Recurrence | 1 | 2004 | 8509 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2007 | 8543 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2002 | 4035 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1994 | 42669 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2007 | 14783 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 15454 | 0.010 |
Why?
|
| Survival Rate | 1 | 2004 | 12840 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2007 | 12168 | 0.000 |
Why?
|
| United States | 1 | 2014 | 73039 | 0.000 |
Why?
|
| Child | 1 | 1994 | 80917 | 0.000 |
Why?
|
| Young Adult | 1 | 2010 | 60066 | 0.000 |
Why?
|
| HIV-1 | 1 | 2000 | 6961 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2007 | 54926 | 0.000 |
Why?
|
| HIV Infections | 1 | 2000 | 17569 | 0.000 |
Why?
|